OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,191 | -39.1% | 4,201 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $21,677 | -2.1% | 4,201 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $22,139 | +68.9% | 4,201 | -10.0% | 0.00% | 0.0% |
Q4 2022 | $13,111 | -32.3% | 4,666 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $19,364 | +98.8% | 4,666 | +92.6% | 0.00% | – |
Q2 2022 | $9,740 | -61.0% | 2,423 | -52.0% | 0.00% | -100.0% |
Q1 2022 | $24,988 | -80.8% | 5,048 | -73.0% | 0.00% | -50.0% |
Q4 2021 | $130,367 | -34.8% | 18,704 | -6.5% | 0.00% | -33.3% |
Q3 2021 | $200,040 | -29.5% | 20,004 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $283,657 | -3.8% | 20,004 | +11.3% | 0.00% | 0.0% |
Q1 2021 | $295,003 | -24.2% | 17,977 | -4.4% | 0.00% | -33.3% |
Q4 2020 | $389,181 | +172.0% | 18,801 | 0.0% | 0.01% | +100.0% |
Q3 2020 | $143,076 | +12.6% | 18,801 | +23.3% | 0.00% | +50.0% |
Q2 2020 | $127,033 | +72.9% | 15,250 | +2.7% | 0.00% | 0.0% |
Q1 2020 | $73,468 | -99.9% | 14,842 | +21.1% | 0.00% | +100.0% |
Q2 2018 | $82,749,000 | +51943.4% | 12,259 | -28.5% | 0.00% | 0.0% |
Q2 2017 | $159,000 | +14.4% | 17,157 | +73.5% | 0.00% | 0.0% |
Q3 2015 | $139,000 | -33.2% | 9,887 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $208,000 | – | 9,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
Covestor Ltd | 60,008 | $316 | 0.28% |
Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |